Genotype | Controls N=100 | Patients | ||
---|---|---|---|---|
Total N=68 | <50 n=43 | >50 n=25 | ||
Factor V Leiden | ||||
GA | 3(3%) | 3(4,41%) | 3(6,67%) | 0 |
GG | 97(97%) | 65(95,59%) | 40(93,33%) | 25(100%) |
Prothrombin | ||||
GA | 2(2%) | 1(1,47%) | 1 (2,38%) | 0 |
GG | 98(98%) | 67(98,53%) | 42(97,62%) | 25(100%) |
MTHFR | ||||
TT | 7(7%) | 4(5,88%) | 1(2,32%) | 3(12%) |
CT | 42(42%) | 35(51,47%) | 22(51,16%) | 13(52%) |
CC | 51(51%) | 29(42,65%) | 20(46.52%) | 9(36%) |
TPA | ||||
DD | 18(18%) | 13(19,12%) | 8(18,6%) | 5(20%) |
ID | 37(37%) | 38(55,88%)a | 21(48.83%) | 17(68%)b |
II | 45(45%) | 17(25%) | 14(32,57%) | 3(12%) |